NEURODRIFT Lab

Lab

The body as an operating system, not wellness: inflammation as technical debt, sleep as a maintenance window, VO2max as a bank statement, GLP-1 as the remote for desire, psoriasis as an overload dashboard. Plus civilization’s material backend — biotech, longevity, CRISPR, chips and data centers. The part that bills you for your lifestyle and your hardware — not just the software.

8 publications

21 min

Dentistry Breakthroughs 2010–2026: Teeth Are Scanned and Printed but Not Regrown, and 45% of People Still Have Dental Disease

A factual review of fifteen years of dentistry: what is actually available in EU clinics in 2026 (scanners, clear aligners, ceramic crowns, tissue-sparing caries treatment, gum surgery, implants) and what is still in research (tooth regrowth in Japan, stem cells, enamel regrowth). An interactive diagram of the tooth and implant, a map of 44 technologies, a navigator by problem, 18 charts.

  • dentistry
  • medicine
  • dental implants

1 min

The evolution of robotics to 2040: 5m robots in factories, 22,000 humanoids in six months, and what will make it out of the lab

A NeuroDrift briefing: a short history of robots from automata to Unimate, 100 milestones from 2000 to 2026, where robots already make money (factories, warehouses, surgery, robotaxis), humanoids and vision-language-action models, lab prototypes on the TRL scale, Ukraine’s ground robots and forecasts for 2035–2040. 11 charts, 2 calculators.

  • lab
  • robots
  • humanoids

1 min

Cultivated meat to 2040: $3.4bn invested, funding down 95% and capacity below a thousandth of a percent of world meat output. Why the breakthrough stalled

A NeuroDrift briefing on why cultivated meat has not taken off. Funding fell from $1.5bn in 2021 to $74m in 2025, the best plant models give $13–37 a kg, four jurisdictions allow sales while at least eight US states, Italy and Hungary ban them. 92 milestones, 15 charts, calculators for beef parity and plants needed by 2040.

  • lab
  • cultivated meat
  • alternative protein

26 min

Psoriasis Treatment Over a Decade: The Best Injections Leave 85–91% of Patients with Almost Clear Skin, Pills 50–58%

A fact-based analysis of how, between 2016 and 2026, IL-17 and IL-23 blockers made almost clear skin a realistic goal of treatment, why each new generation of pills (apremilast, deucravacitinib, icotrokinra) was 1.5–1.8 times better than the last but still falls short of the best injections, what it costs in Europe and Ukraine, and which drugs may appear by 2030. 21 charts and diagrams.

  • psoriasis
  • medicine
  • pharmaceuticals

17 min

GLP-1 vs Willpower: an Injection That Turns Off Food Noise — and a Revision of Self-Control Ethics at $16,000 a Year

For 80 years, Western ethics told fat people to 'get a grip.' In 2024, a once-a-week injection switched off the 'food noise' — and it turned out willpower was never a virtue. It was a tax on people whose biology billed them more. A dissection of the era where self-control is sold in a syringe: Novo Nordisk, worth more than its own country; how every vice eventually gets renamed into a molecule; thinness as a logo of solvency; the vanishing of 'wanting'; and the question of what you'll be moral with once the choice disappears.

  • laboratory
  • biotech
  • GLP-1

7 min

The Energy Bill of AI Infrastructure: 21% of Ireland's Grid Goes to Data Centers, Three Mile Island Restarts for Models

In the 13th century, a city that wanted to be taken seriously built a cathedral. In 2026, it builds a data center. Both burn invisible things (prayer / electricity) for invisible payoffs (God / model). A dissection of the new religious architecture of the 21st century — where the coolers hum, why Three Mile Island is being switched back on, and why Microsoft signed a 20-year deal for a power plant that went bankrupt in 1979.

  • infrastructure
  • AI
  • energy